What is Lifecore Biomedical, Inc.'s net change in cash?

Lifecore Biomedical, Inc. (LFCR) reported net change in cash of $3.33M in Q1 2026.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Lifecore Biomedical, Inc. LFCR Net Change in Cash

Net Change in Cash at other companies

Baxter InternationalBAX

$51M+143%

Thermo Fisher ScientificTMO

-$6.6B-5,099%

ADMA BiologicsADMA

$50.52M+260%

Medpace Holdings, Inc.MEDP

$155.63M+168%

Biodesix, Inc.BDSX

$6.59M+176%

ClearPoint NeuroCLPT

-$10.46M-35.5%

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s net change in cash?: Lifecore Biomedical, Inc. (LFCR) reported net change in cash of $3.33M in Q1 2026.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.